CytomX Therapeutics Inc（CTMX）价格预测CTMXCytomX Therapeutics Inc

Alphio's CTMX stock price prediction model matches the current CytomX Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.45 (+0.32%). The 1-week path is $2.32 (-4.90%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

CytomX Therapeutics Inc is not a good buy right now. The current price is $2.28, which is significantly below the average analyst price target of $11 to $14, indicating potential upside. However, the stock has seen a staggering 46.35% year-to-date decline and a 92.4% year-over-year revenue drop to $1.42 million, which raises serious concerns about its financial health. The RSI is at 33.876, indicating oversold conditions, but the overall negative sentiment from recent earnings misses and cash reserve declines suggests caution. The main risk is the company's substantial revenue decline and ongoing losses, as evidenced by a net income of -$20.67 million in Q2 2026, which could further impact investor confidence and stock performance.

CytomX Therapeutics Inc (CTMX) last closed at $2.44, gaining +1.67%. These facts feed the 1-day and 1-week CTMX price prediction above.